Cinchonism

Revision as of 16:40, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Cinchonism": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cinchonism
ICD-10 T37.2
ICD-9 386.9, 961.4
DiseasesDB 11124

WikiDoc Resources for Cinchonism

Articles

Most recent articles on Cinchonism

Most cited articles on Cinchonism

Review articles on Cinchonism

Articles on Cinchonism in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cinchonism

Images of Cinchonism

Photos of Cinchonism

Podcasts & MP3s on Cinchonism

Videos on Cinchonism

Evidence Based Medicine

Cochrane Collaboration on Cinchonism

Bandolier on Cinchonism

TRIP on Cinchonism

Clinical Trials

Ongoing Trials on Cinchonism at Clinical Trials.gov

Trial results on Cinchonism

Clinical Trials on Cinchonism at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cinchonism

NICE Guidance on Cinchonism

NHS PRODIGY Guidance

FDA on Cinchonism

CDC on Cinchonism

Books

Books on Cinchonism

News

Cinchonism in the news

Be alerted to news on Cinchonism

News trends on Cinchonism

Commentary

Blogs on Cinchonism

Definitions

Definitions of Cinchonism

Patient Resources / Community

Patient resources on Cinchonism

Discussion groups on Cinchonism

Patient Handouts on Cinchonism

Directions to Hospitals Treating Cinchonism

Risk calculators and risk factors for Cinchonism

Healthcare Provider Resources

Symptoms of Cinchonism

Causes & Risk Factors for Cinchonism

Diagnostic studies for Cinchonism

Treatment of Cinchonism

Continuing Medical Education (CME)

CME Programs on Cinchonism

International

Cinchonism en Espanol

Cinchonism en Francais

Business

Cinchonism in the Marketplace

Patents on Cinchonism

Experimental / Informatics

List of terms related to Cinchonism

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cinchonism or quinism is a pathological condition in humans caused by an overdose of quinine or its natural source, cinchona bark. Quinine is used to treat resistant malaria, nocturnal muscle cramps and can also act as an abortifacient. In much smaller amounts, quinine is an ingredient of tonic drinks, acting as a bittering agent. Cinchonism can occur from therapeutic doses of quinine, either from one or several large doses, or from small doses over a longer period of time, not from the amounts used in tonic drinks, but possibly from ingestion of tonic water as a beverage over a lengthy period of time. Quinidine (Class 1A anti-arrhythmic) can also cause cinchonism.

Signs and Symptoms

Symptoms of mild cinchonism (which may occur from standard therapeutic doses of quinine) include flushed and sweaty skin, ringing of the ears (tinnitus), blurred vision, impaired hearing, confusion, reversible high-frequency hearing loss, headache, abdominal pain, rashes, lichenoid photosensitivity [3], vertigo, dizziness, dysphoria (feeling uneasy), nausea and vomiting, and diarrhea.

Large doses of quinine may lead to severe symptoms of cinchonism: skin rashes, deafness, somnolence, diminished visual acuity or blindness, anaphylactic shock, and disturbances in cardiac rhythm or conduction, death from cardiotoxicity. Quinine overdose can also result in a rare form of hypersensitivity reaction termed blackwater fever that results in massive hemolysis, hemoglobinemia, hemoglobinuria, and renal failure.

Patients treated with quinine may also suffer from hypoglycemia (especially if administered intravenously) and hypotension (low blood pressure). In very high doses (higher than those used to treat malaria) during the first trimester of pregnancy quinine may act as an abortifacient, or cause birth defects, especially deafness.

Most symptoms of cinchonism (except in severe cases) are reversible and disappear once quinine is withdrawn.

External links

Template:Diseases of the ear and mastoid process Template:Poisoning and toxicity Template:SIB


Template:WikiDoc Sources